Factors predicting survival after post‐transplant hepatocellular carcinoma recurrence

Abstract

This study suggests that patients with early post-transplant HCC recurrence have worse outcomes. Those with a history of graft rejection have better survivals, possibly due to more active anti-cancer immunity.